MediConnect (MEDI) ICO calificación y detalles

ICO

20 feb 2019

3 abr 2019

100% terminado

Fondos recaudados - sin datos

past

Private sale

16 ene 2019

6 feb 2019

100% terminado

Fondos recaudados - sin datos

10 000 000.00 USD

past

Detalles del token

Corazón

MEDI

Monedas aceptadas

BTC, STRAT

Detalles de la compañía

País registrado

United Kingdom

Detalles adicionales

KYC

Sí

Categorías

Plataforma

Acerca de MediConnect

La red de seguridad para pacientes, recetadores, farmacias y fabricantes de medicamentos.

Con todos los organismos reguladores dentro del sector farmacéutico reconociendo y preocupados por el creciente problema de la prescripción excesiva de medicamentos recetados en línea, MediConnect puede ofrecer una solución a este problema cada vez mayor.

Prescriptores & amp; las farmacias que utilizan MediConnect tendrán la confianza de que al utilizar nuestra solución de cadena de bloqueo, el uso indebido y la prescripción excesiva de medicamentos recetados a posibles adictos & ndash; que normalmente compraría en línea por medicamentos y ndash; serán eliminados.

Se les dará a los pacientes la seguridad de que el medicamento que se les prescribe es genuino y que proviene de un fabricante, prescriptor y una farmacia con licencia que utiliza una solución estándar para ayudarlo a mejorar su propio deber de atención.

MediConnect Roadmap

Q1 2018

Conceived Idea and scoped out requirements of a Prescription Drug Addiction Database.

Q2 2018

Agreed blockchain platform partnership with Stratis.

Q3 2018

Presented idea of a regional trial of East Midlands Pharmacies with newly formed Nottingham Addiction Safeguarding Committee.

Q4 2018

Jason Timms appointed chair of the official Prescription Drug Addiction (PDA) Working Group with the BBFA to tackle over prescribing, drug recalls, counterfeit drug reduction.
Agreed contract start date with ASC Nottingham for Q2 2019 and the onboarding of 2 Pharmacies to MediConnect.
Attended all Chairperson Meeting of the BBFA working groups to look at collaborative opportunities of the PDA on legal, identity, master data, assurance and Cybersecurity working groups.

Lee mas

Q1 2019

ICO Public Sale.
PDA Working Group meeting – Invites to attend to CQC, MHRA, GPhC, LPC, Pharma wholesale and retail industry.

Q2 2019

Commence contract with the ASC to support the Nottingham Trial and UK roll out programme.
Tower Pharmacy & UK Meds will be first 2 Pharmacies on the ASC blockchain solution from MediConnect.
6 other Pharmacies will be integrated, including 1 NHS Hospital outpatient dispensing pharmacy.

Q3 2019

Collaboration with Local Pharmacy Groups and membership committee to inform on pilot and expand reach to 20 further pharmacies in Nottingham, Derby & Leicester.
Partnership with Pharmacy Wholesaler – implementation of drug recall and counterfeit medication system.

Q4 2019

Publish trial research and outcomes – present at PDA meeting to CQC, MHRA. GPhC, LPC and Industry.

Q1 2020

The MediConnect platform will demonstrate an improved duty of care and detection that will see a reduction in pharmacy insurance for Pharmacies.

Q2 2020

Will see the recruitment of 500 UK Pharmacies join MediConnect through the expansion of the ASC membership in the UK.

Q3 2020

Aim for MediConnect to be the Industry standard solution for traceability of drugs for recall and counterfeit medication detection.

Q4 2020

The ASC achieves it’s goal of UK Pharmacies required to be members of the ASC and the MediConnect platform is used by all UK pharmacies